About Salmeterol (as Salmeterol
Xinafoate)Salmeterol Xinafoate
36.32 mcg/shot 36.32 mcg
of Salmeterol xinafoate is
equivalent to 25 mcg of Salmeterol
Fluticasone Propionate250
mcg/shot
Inhaled corticosteroid and long-acting beta agonist
Used for Long-term control of asthma Maintenance treatment of chronic obstructive pulmonary disease (COPD) Usual adult dose Asthma: usually 1 inhalation twice daily; COPD dosing depends on the product and prescribed regimen.
Usual dose in children Asthma: for ages 4 and older, usually 1 inhalation twice daily; age-specific product instructions apply.
Common side effects Hoarse voice or throat irritation Oral thrush Headache Tremor or palpitations Important warnings Not for sudden breathing attacks; use a quick-relief inhaler. Rinse mouth and spit after each dose to reduce thrush risk. Do not use with another salmeterol-containing medicine. Seek urgent care for worsening breathing or allergic symptoms. Pregnancy Use only when needed for asthma control; discuss risks and benefits with a healthcare professional.
Breastfeeding Use with professional guidance; inhaled treatment may be continued when needed to control asthma.
Interactions Other long-acting beta agonists may increase side effects. Strong CYP3A4 inhibitors, such as ritonavir or ketoconazole, can increase exposure. Beta blockers may reduce bronchodilator effects and worsen breathing. AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.
Report this summary